Sporozoites that have undergone radiation. The PfSPZ vaccine has been in development by the company. The premise of the vaccine is use to use these radiated sporozoites inside the body to bring forth an attack on the sporozoite, which will help the body prevent itself against further attacks of malaria. Due to its promising nature, the U.S FDA department granted it the fast track designation in 2016.
